Pablo Valenzuela Valdés
Founder and Scientific Director
Fundación Ciencia & Vida
Santiago, Chile
Pioneer in the global biotechnology industry. Development of vaccines and products for human health, food industry and blood banking. Currently, his research focuses on the development of a novel drug for cancer treatment.
-
Biochemistry, UNIVERSIDAD DE CHILE. Chile, 1965
-
Biochemistry, Northwestern University. Estados Unidos, 1970
-
Postdoctoral fellow Full Time
UNIVERSITY OF CALIFORNIA-SAN FRANCISCO
San Francisco, Estados Unidos
1970 - 1971
-
Full Professor Full Time
PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE
Biological Sciences
Santiago, Chile
1972 - 2009
-
Adjunct Associate Professor Full Time
UNIVERSITY OF CALIFORNIA-SAN FRANCISCO
San Francisco, Estados Unidos
1977 - 1981
-
Professor, Founder and Director Graduate Program in Biotechnology Other
UNIVERSIDAD ANDRES BELLO
Santiago, Chile
2002 - A la fecha
-
Founder and Vice-President of Research and Development Full Time
Chiron Corporation
Estados Unidos
1981 - 1996
-
Founder and Chairman of the Board Full Time
Grupo Bios S. A.
Chile
1986 - 2016
-
President Other
Chiron Diagnostics
Estados Unidos
1995 - 1997
-
Founder and Scientific Director Full Time
Fundación Ciencia & Vida
Santiago, Chile
1997 - A la fecha
-
Member of the Board of Directors Other
PraxSys Biosystems Inc.
Estados Unidos
1997 - 2003
-
Senior Vice President Emeritus Other
Chiron Corporation
Chile
1998 - A la fecha
-
Member of the Board of Directors Other
Applied Imaging Inc.
Chile
2000 - 2007
-
Cofounder and Director Full Time
Millennium Institute for Fundamental and Applied Biology (MIFAB)
Santiago, Chile
2000 - 2009
-
Member Other
Chilean Academy of Sciences
Chile
2004 - A la fecha
-
Board Member Other
Algenis SpA
Chile
2005 - A la fecha
-
Member of the Scientific Advisory Board Other
Medivation Inc.
Estados Unidos
2008 - A la fecha
-
Board Member Other
Austral Capital
Santiago, Chile
2008 - A la fecha
-
Member of the Advisory Board Other
AurusBio
Santiago, Chile
2009 - A la fecha
-
Founder and Chairman Other
Andes Biotechnologies S.A.
Santiago, Chile
2009 - A la fecha
-
Member Other
Consejo Nacional de Innovación para la Competitividad
Chile
2010 - 2014
-
Board Member Other
Phage Technologies S.A.
Chile
2010 - A la fecha
-
Board Member Other
Zentynel Ltda.
Chile
2012 - A la fecha
-
Board Member Other
Nova Mineralis SpA
Chile
2014 - A la fecha
-
Board Member Other
Lab4U
Estados Unidos
2014 - A la fecha
Investigator and graduate professor with academic trajectory:
- Professor participating in doctorate programs at various Chilean universities
- Director of Ph.D. Program in Biotechnology at Universidad Andrés Bello.
- Member of the Directive Board Universidad San Sebastián, Santiago, Chile.
- Creator of strong ties with the University of California in San Francisco, with which he maintains an academic exchange in the Department of Biochemistry and Biophysics and the Cancer Center.
- Author of more than 130 international publications in molecular biology and biotechnology and named inventor in more than 50 international patents.
* Scientist with ample experience in the direction and management of science and technology in the U.S. Co-founder and VP of R&D at the Chiron Corporation (1981-1996), one of the 3 early emblematic biotechnology companies in the U.S. This management included directing scientific and technological investigations, hiring scientists and engineers, and preparing and executing budgets, reports, and presentations for boards, investors, members of investment banks, and NASDAQ analysts.
* Scientist and entrepreneur with extensive experience in intellectual property and technology transfer. Has participated in the licensing and transfer of Chiron Corporation’s technologies to several companies (Pharmacia, Merck, Johnson & Johnson, Abbott, etc.) and in the transfer of technologies from the Fundación Ciencia y Vida to an international company (Novartis). An inventor in more than 50 patent applications in Chile and abroad. Director of research activities resulting in more than 200 patent applications in which he is not an inventor.
* Responsible for the development of multiple technologies and biotechnology products (in the USA) using genetic engineering, among them:
- ten products in the area of international diagnostics and blood banking (Hepatitis C, AIDS, Hepatitis B).
- four products in the pharmaceutical area (Hepatitis B vaccine, human insulin, beta-interferon and a wound-healing factor) and one product for the food industry (bovine rennin).
These products, which are commercialized by Johnson & Johnson, Merck, Novo-Nordisk, Abbott and Gist Brocades, command today more than 15 billion dollars in sales.
* Responsible for the development of multiple technologies and biotechnology products (in Chile), among them:
- vaccines for the salmon aquaculture (one product already on the market).
- products for human health and blood banking (Chagas, Helicobacter, rotavirus, blood tests, viral antigens, etc.).
All these products are commercialized in Chile and Latin America, with current sales of approximately 15 million dollars per year.
* Co-founder and responsible for the initial activities of biotechnology start-ups (Chiron Corporation, Ventria Biosciences, Austral Biologicals, GrupoBios S.A., Phytotox S.A., Andes Biotechnologies S.A.) and BiosCell with a market value of more than 5 billion dollars.
* Entrepreneur with experience in financing biotechnology start-ups through angel investors, venture capital, and initial public offerings. Has participated in the early financing and capital increases of companies mentioned above (Chiron Corporation, GrupoBios S.A., Ventria Biosciences, Applied Imaging, Phytotox S.A., and Andes Biotechnologies S.A.) for a total of nearly 100 million dollars.
* Under his administration, Fundación Ciencia & Vida has developed a “Science and Business Park” with more than 15 participating institutions, such as the foreign companies Austral Biologicals, The Tree Lab, Medivation Inc., Green Pacific Biologicals, EvolveMol Inc., Sanivation Inc. and Ventria Bioscience, as well as the Chilean start-ups Phage Technologies S.A., GrupoBios S.A., Zentynel Ltda., Digital Education S.A., BiosCell S.A. and Invitae.
* National Chilean Prize in Applied Sciences and Technology (2002)
-
Fulbright Fellowship
Fulbright Program
Estados Unidos, 1967
Fulbright Program: American scholarship program of competitive, merit-based grants for international educational exchange for students, scholars, teachers, professionals, scientists and artists.
-
Fogarty International Fellowship
NATIONAL INSTITUTES OF HEALTH (NIH)
Estados Unidos, 1974
The Fogarty International Center at NIH offers a variety of funding opportunities to support the field of global health research.
-
Science Merit Award
UNIVERSIDAD ANDRES BELLO
Chile, 2001
Science Merit Award Universidad Andrés Bello
-
Presidential Medal
UNIVERSIDAD DE CHILE
Chile, 2002
Presidential Medal
-
National Award in Applied Sciences and Technologies
COMISION NACIONAL DE INVESTIGACION CIENTIFICA Y TECNOLOGICA
Chile, 2002
Chilean National Award in Applied Sciences and Technologies
-
Doctor Honoris Causa
UNIVERSIDAD DE TARAPACA
Chile, 2003
Doctor Honoris Causa
-
Doctor Honoris Causa
UNIVERSITE DE BORDEAUX II
Francia, 2005
Doctor Honoris Causa
-
Doctor Honoris Causa
UNIVERSIDAD SAN SEBASTIAN
Chile, 2009
Doctor Honoris Causa
-
Order of the Southern Cross Medal
GOBIERNO DE CHILE
Chile, 2012
Medalla Orden de la Cruz del Sur
-
Lifetime Achievement Award
Life Sciences Association of Northern California
Estados Unidos, 2012
Lifetime Achievement Award
-
Bicentenario Medal
CONGRESO NACIONAL
Chile, 2011
Medalla Bicentenario
-
Alumnus of the Year Award
UNIVERSITY OF CALIFORNIA-SAN FRANCISCO
Estados Unidos, 2013
Distinguished Alumnus of the Year Award, University of California at San Francisco
-
UCSF Medal
UNIVERSITY OF CALIFORNIA-SAN FRANCISCO
Estados Unidos, 2014
UCSF Medal For Advancing Health Worldwide
-
WIPO Gold Medal for Inventors
World Intellectual Property Organization
Suiza, 2015
Medal World Intellectual Property Organization
-
The Third World Academy of Sciences Award
THIRD WORLD ACADEMY OF SCIENCES
Italia, 2016
Regional Prize for Building Scientific Institutions 2016
Development of a recombinant vaccine against ISA virus based on synthetic genes |
Preliminary genomic and functional analysis of a cDNA library from Botrytis cinerea |
Insights into the metabolism and ecophysiology of three acidithiobacilli by comparative genome analysis |
Transcription and integration of hepatitis B virus |